Pharmaceutical

ImPact enters partnership for pathologic myopia therapy development

ImPact Biotech entered into a partnership with Maastricht University to develop a therapy for arresting pathologic myopia progression.

Aug 14, 2023 - 20:00
ImPact enters partnership for pathologic myopia therapy development
ImPact Biotech entered into a partnership with Maastricht University to develop a therapy for arresting pathologic myopia progression.
Read the original article

Tags:

Previous Article

RNA-LNPs: Navigating the regulatory challenges

Next Article

Biopharma firm Zetagen raises $9.79m in Series B financing round

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Pfizer’s colorectal cancer combo therapy gains accelerated approval from FDA

Pfizer’s colorectal cancer combo therapy gains accelera...

Dec 23, 2024

In his State of the Union, Biden takes clear aim at ‘Big Pharma’

In his State of the Union, Biden takes clear aim at ‘Bi...

Mar 8, 2024

As NIH grant runs out, Dog Aging Project founders look to raise up to $50 million

As NIH grant runs out, Dog Aging Project founders look ...

Jan 24, 2024